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Systemic lupus erythematosus (SLE), systemic scleroderma (SSc) and idiopathic inflammatory 
myositis (IIM) are systemic autoimmune diseases characterized by autoantibodies (AutoAbs) against 
various self-antigens. In this study, we measured the serum IgA AutoAbs against 124 self-antigens in 
a cohort of 128 SLE, 73 SSc, 75 IIM and 140 healthy controls (HC) using autoantigen microarrays. 
Our result indicated that IgA AutoAbs were highly prevalent in SLE and SSc compared with IIM and 
NC. 58.4% SLE and 41.7% SSc have 5 or more IgA AutoAbs compared with 16% in IIM and 14.1% in 
NC. 9 IgA AutoAbs most significantly elevated in SLE were anti-DNA antigens including dsDNA 
(54.7%), ssDNA (51.1%), and chromatin (46%). 32 IgA AutoAbs were significantly increased in SSC 
with highest reactivity to Scl-70 (55.6%). IIM showed lower prevalence of IgA AutoAbs with highest in 
anti- Jo-1 (20%), anti-muscarinic receptor (8%) and anti-B2-microglubulin (6.7%). Significant 
correlation was observed between IgA and IgG isotypes on most AutoAbs. 3 IgA autoAbs (anit-gDNA, 
anti-C1q and anti-dsDNA) positively correlated with SLEDAI Score, but only anti-C1q IgA was 
significantly elevated in lupus nephritis. 14 anti-nuclear IgA AutoAbs negatively correlated with serum 
complement C3 and/or C4 levels. Our study indicated that autoreactive IgA AutoAbs against nuclear 
components, in parallel with IgG AutoAbs, are highly prevalent in SLE and SSC patients. IgA AutoAbs 
could be used as biomarkers for diagnosis and prognosis of systemic autoimmune diseases, and the 
molecular mechanisms underlining IgA AutoAbs production in systemic autoimmune diseases warrant 
further study.  
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Type 1 diabetes (T1D) is characterized by a CD8+ lymphocyte-mediated selective destruction of the 
insulin-producing β-cells causing clinical diabetes. Several autoantigens including glutamic acid 
decarboxylase 65kDa (GAD65), insulin, protein tyrosine phosphatase (IA-2) and zinc transporter 8 
(ZnT8) have been identified based on reactivity in sera from T1D individuals. Here we investigate if 
post-translational deamination of arginine in the form of citrullination plays a role in T cell recognition of 
T1D autoantigens. Citrullination may lead to generation of neo-epitopes, which has been described as  
T cell targets in other autoimmune diseases. We used netMHC prediction algorithm to identify 764 
epitopes from Insulin, GAD65, IA-2 and ZnT8 restricted to HLA-A2, A24, B8 and B15. Among these 91 
peptide sequences were susceptible for citrullination. We evaluate the MHC-affinity of both the 
citrullinated and non-citrullinated library, to identify potential neo-epitopes and to understand the 
impact of citrullination on MHC affinity. In parallel we will analyse peripheral blood lymphocytes from 
50 T1D patients for immune reactivity against the full library. The large library screen will be conducted 
applying a novel technology where the selection of MHC-multimer binding T cells is followed by 
amplification and sequencing of MHC multimer-associated DNA barcodes revealing their recognition. 
This technique enables simultaneous detection of >1000 specificities. Identifying post translational 
modifications capable of eliciting autoreactive T cell responses in T1D patients is highly relevant for 
understanding the underlying mechanisms leading to T1D.  
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